SCHEMBL22729244

SCHEMBL22729244

N#Cc1cccc(-n2c3ccccc3c3ccccc32)c1-c1c(C#N)cncc1-n1c2ccccc2c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HIF1A Q16665 1/20 0.36
IMPDH2 P12268 1/20 0.36
ALDH1A1 P00352 4/20 0.35
HTT P42858 2/20 0.35
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AR P10275 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
RPS6KB1 P23443 1/20 0.32
ROCK1 Q13464 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP19A1 P11511 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19062208 0.88 CA1 (0.44) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL19062219 0.84 CA1 (0.43) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL21396775 0.83 HTT (0.41) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL23855965 0.81 SMN1; SMN2 (0.40) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL21396951 0.81 SMN1; SMN2 (0.35) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL21396778 0.80 HTT (0.41) CA1CA2SMN1; SMN2HIF1AHTT
SCHEMBL19755213 0.80 CA1 (0.40) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL21687786 0.77 SMN1; SMN2 (0.36) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL21396673 0.77 SLC6A9 (0.36) CA1CA2SMN1; SMN2HIF1AIMPDH2
SCHEMBL22327576 0.77 CA1 (0.38) CA1CA2SMN1; SMN2HIF1AIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200381631-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200381631-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS DRD5, DRD1, DRD2 CA1 3834/4885CA2 4306/4885SMN1; SMN2 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.